We at TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP, assure patients have a better access to controlled substance active pharmaceutical ingredients (API) to meet the needs of many indication fields including depression, post-traumatic stress disorder (PTSD), addiction, and pain management.

We are strongly convinced that distribution is creating a vast basket of added values to our customers and patients. One of the main values is to secure the steady supply of APIs; which has been proven during the current Covid-19 pandemic, the BREXIT, and exponentiates itself due to the requirement of “just in time deliveries”. Healing risks of out-of-stock scenarios and keeping a security buffer stock level is more important than ever. TIEFENBACHER API + INGREDIENTS has the necessary expertise, capabilities, and infrastructure to supply all APIs in line with increasingly stringent regulatory requirements to Europe.

Besides our strong pain treatment portfolio like Morphine, Buprenorphine, Oxycodone HCl and Hydromorphone HCl we also offering high potency products for intensive care like Sufentanil and Fentanyl. Furthermore, products like Methylphenidate and Dexamfetamine against the ADHS are completing our portfolio. We possess all the knowledge of regulations and can prove a strong track record of working with controlled substances, which is essential when ensuring the compliant handling of APIs and accelerating products from development to commercialization in the pharmaceutical industry.

Controlled substances combine with all regulations requirements are constantly available – and our whole portfolio includes more than 600+ APIs (Human + Veterinary) to secure the healthcare industry. For more information, please contact TIEFENBACHER API + INGREDIENTS:

Frank Tettinger f.tettinger@tifi-api.eu
Or please visit us on our TIEFENBACHER API + INGREDIENTS Website: www.tiefenbacher-api.com